Hai Tran
Associate Director,
EpiBiologics
Hai Tran is a principal scientist at EpiBiologics, a company focused on developing antibody-based extracellular and membrane protein degraders. He received his PhD from UCSF in the laboratory of Professor Jim Wells. His previous experience includes developing switchable bispecific T-cell engagers at Soteria Biotherapeutics and engineering brain delivery at Denali Therapeutics.
Sessions
-
23-Sep-2024Executive BoardroomWhat is the optimum human CDR-H3 repertoire for antibody discovery?